Novo Integrated Sciences Accounts Payable

As of the most recent data (August 2024), NVOS shows a accounts payable of $3.2M. That compares with $3.5M in the prior-year period — down 7.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVOS's accounts payable is now $3.2M (was $3.5M) — a 7.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Novo Integrated Sciences is outperforming or lagging.

Tracking NVOS's accounts payable over time shows whether Novo Integrated Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $3.2M That compares with $3.5M in the prior-year period — down 7.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Novo Integrated Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $3.2M) with ownership activity and broader fundamentals.

Novo Integrated Sciences's accounts payable is $3.2M; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.